HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GSK2336805

has antiviral activity

Also Known As:

JNJ-56914845

Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Carbamates: 945
      - GSK2336805: 5
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Branched-Chain Amino Acids: 2289
    - Valine: 1999
      - GSK2336805: 5
  - Essential Amino Acids: 1152
    - Valine: 1999
      - GSK2336805: 5

Experts

1.	Van Remoortere, Pieter: 2 articles (02/2017 - 01/2017)
2.	Vandebosch, An: 2 articles (02/2017 - 01/2017)
3.	Verloes, René: 2 articles (02/2017 - 01/2017)
4.	Vijgen, Leen: 2 articles (02/2017 - 01/2017)
5.	Gardner, Stephen: 2 articles (09/2015 - 07/2014)
6.	Arastéh, Keikawus: 1 article (02/2017)
7.	Bourgeois, Stefan: 1 article (02/2017)
8.	Buggisch, Peter: 1 article (02/2017)
9.	Francque, Sven: 1 article (02/2017)
10.	Hoeben, Eva: 1 article (02/2017)

Related Diseases

1.	Chronic Hepatitis C 07/01/2014 - "GSK2336805 is a HCV NS5A inhibitor for chronic hepatitis C (CHC). " 10/01/2013 - "GSK2336805 is a hepatitis C virus NS5A inhibitor in clinical development for the treatment of chronic hepatitis C virus infection. " 09/01/2015 - "JNJ-56914845 (GSK2336805) is a hepatitis C virus nonstructural protein 5A inhibitor under development for the treatment of chronic hepatitis C (CHC) infection. " 01/01/2017 - "In study TMC647055HPC2001, a 3-direct-acting-antiviral (DAA) regimen combining NS3/4A protease inhibitor simeprevir (SMV), non-nucleoside NS5B inhibitor TMC647055/ritonavir (RTV) and NS5A inhibitor JNJ-56914845 resulted in high sustained virologic response 12 weeks after actual end of treatment (SVR12) in chronic hepatitis C virus (HCV) genotype 1-infected patients. "
2.	Infections 09/01/2015 - "JNJ-56914845 (GSK2336805) is a hepatitis C virus nonstructural protein 5A inhibitor under development for the treatment of chronic hepatitis C (CHC) infection. " 02/10/2017 - "Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection."
3.	Virus Diseases (Viral Diseases) 10/01/2013 - "GSK2336805 is a hepatitis C virus NS5A inhibitor in clinical development for the treatment of chronic hepatitis C virus infection. "

Related Drugs and Biologics

1.	Ritonavir (Norvir)
2.	Simeprevir
3.	27- cyclohexyl- 12,13,16,17- tetrahydro- 22- methoxy- 11,17- dimethyl- 10,10- dioxide- 2,19- methano- 3,7:4,1- dimetheno- 1H,11H- 14,10,2,9,11,17- benzoxathiatetraazacyclo docosine-8,18(9H,15H)-dione
4.	Protease Inhibitors (Protease Inhibitor)
5.	Nucleosides
6.	GSK2336805
7.	Ribavirin (Virazole)
8.	Proteins (Proteins, Gene)